Koyfin Home > Directory > Health Care > Biogen Inc > Total Debt / (EBITDA-CAPEX)

Biogen Inc Total Debt / (EBITDA-CAPEX) Chart (BIIB)

Biogen Inc annual/quarterly Total Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Biogen Inc Total Debt / (EBITDA-CAPEX) for the quarter ending September 09, 2020 was $2m a 46.86% increase of 1m year over year
  • Biogen Inc Total Debt / (EBITDA-CAPEX) for the last 12 months ending September 09, 2020 was $1m a 23.47% increase of 0m year over year
  • Biogen Inc Annual Total Debt / (EBITDA-CAPEX) for 2019 was $1m a -7.93% decrease of 0m from 2018
  • Biogen Inc Annual Total Debt / (EBITDA-CAPEX) for 2018 was $1m a -8.80% decrease of 0m from 2017
  • Biogen Inc Annual Total Debt / (EBITDA-CAPEX) for 2017 was $1m a -9.96% decrease of 0m from 2016
Other Ratios Metrics:
  • Biogen Inc Total Debt / Capital for the quarter ending December 12, 2018 was $31m a 5.08% increase of 2m year over year
  • Biogen Inc Other Liabilities for the quarter ending December 12, 2018 was $3,026m a 1.80% increase of 55m year over year
  • Biogen Inc Total Debt / Equity for the quarter ending December 12, 2018 was $46m a 7.23% increase of 3m year over year
View Chart On Koyfin

Quarterly BIIB Total Debt / (EBITDA-CAPEX) Data

09/2020$2m
06/2020$1m
03/2020$1m
12/2019$1m
09/2019$1m
06/2019$1m
03/2019$1m
12/2018$1m
09/2018$1m
06/2018$1m

Annual BIIB Total Debt / (EBITDA-CAPEX) Data

2019$1m
2018$1m
2017$1m
2016$1m
2015$1m
2014$0m
2013$0m
2012$1m
2011$1m
2010$1m